All antidepressants in use today act via the monoamine neurotransmitters. However, only ∼50% of individuals with depression show full remission. Berton and Nestler review recent development of alternative, non-monoamine-based antidepressants, highlighting the obstacles and some of the most promising strategies.
- Olivier Berton
- Eric J. Nestler
